hexacyanoferrate-iii and Acute-Disease

hexacyanoferrate-iii has been researched along with Acute-Disease* in 1 studies

Other Studies

1 other study(ies) available for hexacyanoferrate-iii and Acute-Disease

ArticleYear
An Electrochemical Biosensor Based on a Myoglobin-specific Binding Peptide for Early Diagnosis of Acute Myocardial Infarction.
    Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2015, Volume: 31, Issue:7

    In this study, a simple, highly sensitive electrochemical biosensor for myoglobin was developed using a myoglobin-specific binding peptide as a sensing probe. A peptide (Myo-3R7, CPSTLGASC, 838 Da) identified by phage display and that specifically binds to myoglobin was covalently immobilized on a gold electrode functionalized via a dithiobis(succinimidyl propionate) (DSP) self-assembled monolayer (SAM). The peptide immobilization was confirmed with fluorescence microarray scanning and cyclic voltammetry (CV). The electrochemical performance of the biosensor with respect to myoglobin was characterized by CV and differential pulse voltammetry (DPV) using Fe(CN)6(3-)/Fe(CN)6(4-) as a redox probe. We successfully detected myoglobin in a broad working range of 17.8 to 1780 ng mL(-1) with a correlation coefficient (R(2)) of 0.998. The estimated limit of detection (LOD) was fairly low, 9.8 ng mL(-1) in 30 min. The electrochemical biosensor based on a myoglobin-specific binding peptide offers sensitivity, selectivity, and rapidity, making it an attractive tool for the early detection of cardiac infarction.

    Topics: Acute Disease; Amino Acid Sequence; Biosensing Techniques; Early Diagnosis; Electrochemistry; Ferricyanides; Gold; Humans; Limit of Detection; Models, Molecular; Myocardial Infarction; Myoglobin; Oligopeptides; Protein Conformation; Substrate Specificity; Succinimides; Time Factors

2015